What Should Be Included in a Canadian Orphan Drug Regulatory Framework
As the new Liberal government turns its mind to the application of substantive policies, it will have to decide what to do with the Canadian
As the new Liberal government turns its mind to the application of substantive policies, it will have to decide what to do with the Canadian
Modern multi-lateral trade treaties do not habitually soften IP protection. The Trans-Pacific Partnership (TPP), signed October 5th, is no exception. With prescription drug costs increasingly weighing on Western nations, does
This article is cross-posted with permission from Bereskin & Parr. The United States Patent and Trademarks Office (USPTO) has released an updated set of Eligibility
This article is cross-posted with permission from Bereskin & Parr. It is very important to provide adequate disclosure when using “means-plus-function” claims in a U.S.
This is an excerpt from a paper by Adam Falconi, the recipient of the 2015 Barry D. Tomo Memorial Prize for best research paper on
United States Supreme Court Justice Elena Kagan is a fan of comics. If you had not already read that in her bio at SCOTUS-tracking blog